Video: Sitting Down With… John Tomtishen

Catalent’s John Tomtishen discusses his path into cell therapy and the evolving approaches to CMC, manufacturing, and commercialization

1

The video interview features John Tomtishen, Catalent’s Global Head of Cell Therapy Field Application Scientists and Strategic Alliances.
2

Tomtishen discusses his career and changes he has witnessed across the cell therapy field.
3

He explains why developers should prioritize product characterization early in development.
4

Tomtishen also emphasizes the importance of addressing chemistry, manufacturing, and controls early in development.
5

He discusses technologies and manufacturing strategies that could improve scalability and the industry’s efforts to bring future cell therapies to more patients.

1